Leslie A Meyer, OD | |
Us Highway 491 North, Shiprock, NM 87420 | |
(505) 368-7115 | |
Not Available |
Full Name | Leslie A Meyer |
---|---|
Gender | Female |
Speciality | Optometry |
Experience | 13 Years |
Location | Us Highway 491 North, Shiprock, New Mexico |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1184903411 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | 3241 (Minnesota) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Northern Navajo Medical Center | Shiprock, NM | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Dhhs Phs Naihs Shiprock Hospital | 0749193837 | 93 |
News Archive
The National Cancer Institute has awarded a $55.4 million, multiple-year contract to Fred Hutchinson Cancer Research Center to become the nation's sole operator of its Cancer Information Service Contact Center.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it has initiated a new Phase III trial designed to evaluate the efficacy, tolerability and safety of pimavanserin as a treatment for patients with Parkinson's disease psychosis (PDP).
Regenstrief Institute and Indiana University Center for Aging Research investigators are testing whether providing nursing homes and the doctors and nurse practitioners who care for their residents with increased Medicare payments can further reduce avoidable hospitalizations.
Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration has approved XIAFLEX (collagenase clostridium histolyticum, or CCH), an in-office, biologic for the treatment of Peyronie's disease. XIAFLEX is the first and only FDA-approved treatment proven effective for PD in men with a palpable plaque and a curvature deformity of 30 degrees or greater at the start of therapy.
› Verified 1 days ago
Provider Name | Dhhs Phs Naihs Shiprock Hospital |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1780639971 PECOS PAC ID: 0749193837 Enrollment ID: O20031105000809 |
News Archive
The National Cancer Institute has awarded a $55.4 million, multiple-year contract to Fred Hutchinson Cancer Research Center to become the nation's sole operator of its Cancer Information Service Contact Center.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it has initiated a new Phase III trial designed to evaluate the efficacy, tolerability and safety of pimavanserin as a treatment for patients with Parkinson's disease psychosis (PDP).
Regenstrief Institute and Indiana University Center for Aging Research investigators are testing whether providing nursing homes and the doctors and nurse practitioners who care for their residents with increased Medicare payments can further reduce avoidable hospitalizations.
Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration has approved XIAFLEX (collagenase clostridium histolyticum, or CCH), an in-office, biologic for the treatment of Peyronie's disease. XIAFLEX is the first and only FDA-approved treatment proven effective for PD in men with a palpable plaque and a curvature deformity of 30 degrees or greater at the start of therapy.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Leslie A Meyer, OD Po Box 160, Shiprock, NM 87420-0160 Ph: () - | Leslie A Meyer, OD Us Highway 491 North, Shiprock, NM 87420 Ph: (505) 368-7115 |
News Archive
The National Cancer Institute has awarded a $55.4 million, multiple-year contract to Fred Hutchinson Cancer Research Center to become the nation's sole operator of its Cancer Information Service Contact Center.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it has initiated a new Phase III trial designed to evaluate the efficacy, tolerability and safety of pimavanserin as a treatment for patients with Parkinson's disease psychosis (PDP).
Regenstrief Institute and Indiana University Center for Aging Research investigators are testing whether providing nursing homes and the doctors and nurse practitioners who care for their residents with increased Medicare payments can further reduce avoidable hospitalizations.
Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration has approved XIAFLEX (collagenase clostridium histolyticum, or CCH), an in-office, biologic for the treatment of Peyronie's disease. XIAFLEX is the first and only FDA-approved treatment proven effective for PD in men with a palpable plaque and a curvature deformity of 30 degrees or greater at the start of therapy.
› Verified 1 days ago
John D Fugate, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: Us Hwy 491north, Northern Navajo Medical Center, Shiprock, NM 87420 Phone: 505-368-7038 | |
Shannon H Lee, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: Hwy 491 North, Northern Navajo Medical Center Optometry Dept, Shiprock, NM 87420 Phone: 505-368-6001 | |
Kia Yang, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: Us Hwy 491 North, Shiprock, NM 87420 Phone: 505-368-6001 Fax: 505-368-7411 | |
Anjali Nicole Paramanandam, OD Optometrist Medicare: Medicare Enrolled Practice Location: Us-491, Shiprock, NM 87420 Phone: 505-368-6001 | |
Elysia Ison, OD Optometrist Medicare: Medicare Enrolled Practice Location: Us Hwy 491 North, Shiprock, NM 87420 Phone: 505-368-6001 | |
Ryan August Peine, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: Us Hwy 491 North, Shiprock, NM 87420 Phone: 505-368-6001 |